Navigation Links
Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
Date:10/3/2007

To enhance equity stake in Zenotech Laboratories to 45%

GURGAON, India, Oct. 3 /PRNewswire/ -- Ranbaxy Laboratories Limited (Ranbaxy) and Zenotech Laboratories Limited (Zenotech) today announced the signing of Definitive Agreements, providing for an increase in equity stake by Ranbaxy from its current 7% to 45% at a price of Rs. 160 per share aggregating to Rs. 214 Crores. This involves:

(a) Purchase of shares from the existing Promoters

(b) Preferential Offer to Ranbaxy by Zenotech

The above triggers a mandatory open offer by Ranbaxy to other shareholders of Zenotech, at a price of Rs. 160 per share or as determined by SEBI regulations.

Post the offer, the existing Promoter Group of Zenotech will have a 25% stake in its expanded equity capital. Dr. Jayaram Chigurupati shall continue as the Managing Director.

Speaking on the development, Mr. Malvinder Mohan Singh, CEO & MD, Ranbaxy, said, "The increasing importance of Biologics in the Global Pharmaceutical industry and the opening up of the generic Biologics in the regulated markets, makes it opportune for Ranbaxy to enhance its presence in this area. Speciality injectables, that include Oncology products, constitute an attractive segment that underpins our strategic intent. Having worked with Zenotech for almost two years, we believe that this investment and partnership provides a strong platform for us to leverage these opportunities."

Commenting on the transaction, Dr. Jayaram Chigurupati said, "Ranbaxy's increase in stake will enable Zenotech to concentrate on its core competencies of cutting edge Drug Development and Specialized Manufacturing. Access to Ranbaxy's unmatched Global market reach, Quality & Compliance and Regulatory & IP expertise will enable us to take the business into its next phase of growth."

Zenotech has received three Indian approvals for Oncology Biopharmaceuticals i.e. GCSF (Granulocyte Colony Stimulating Factor), GM-CSF (Granul
'/>"/>

SOURCE Ranbaxy Laboratories Limited
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Fiserve Acquires RegEd, Consolidates N.C.-Based Operations in Wisconsin
2. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
3. Wisconsin early-stage companies must position themselves to get capital
4. New UW position focusing on Internet security
5. Midwest holds strong position in worldwide diagnostics business
6. Doyle praises Frists new stem cell research position
7. GE promotes Milwaukee-area CEO to London position
8. Is IT leadership a position or an attitude?
9. nPoint announces new nanopositioning scanning control mode
10. A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA)
11. National stem-cell panel, including UW profs, urges close watch on research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , CALGARY and BLENHEIM, Ontario, Nov. 24 /PRN...unced today it is acquiring the assets of Hyland S... Ontario. The addition of Hyland Seeds will furthe...as the company anticipates the introduction of Sm...icide Tolerant Trait Technology in corn in 2012. T...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ ...t & Trademark Office (PTO) has allowed the pat...y or NOD technology. , NOD technology is ...s or,proteins into bio-adhesive nano-particles to ...ed as injections. NOD technology is a platform tec...
(Date:11/24/2009)... , , Primary efficacy endpoint has been me...t endometrial cancer, , QUEBEC CITY, Nov. 24 ...SDAQ: AEZS ; TSX: AEZ) (the "Company"), a global ...rapy and oncology, today announced positive effica...otoxic peptide conjugate, AEZS-108 (formerly AN-15...
(Date:11/24/2009)... , BOZEN, Italy, November 24 /PRNewswir...formed a new Canadian joint venture with a group o...-based company will operate under the,name Health ...d support,Health Robotics, i.v. Room of the Future... offerings i.v.STATION(TM), i.v.SOFT(TM), and OMM(...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
...ear and fourth quarter 2007 preservation services ...pectively, to approximately $93.7 million for the...TLANTA, Jan. 10 CryoLife, Inc. (NYSE: CRY ),a bi...ompany, announced,today that preservation services...$93.7 million compared to $81.1 million in 2006, a...
...esearchers designing and building new microelectro...est method developed at the National Institute of ...echanical property of such systems: elasticity. Th... films not only for MEMS devices but also for semi... 1727, scientists and engineers have used Youngs m...
...meros Corporation announced today that,it has file... Exchange,Commission relating to the proposed init... All shares of the common stock to be sold in the ...Securities Inc. will be acting as,the sole book-ru...e acting,as the co- lead manager, and Leerink Swan...
Other Biology Technology:CryoLife Announces Record Preservation Services and Product Revenues for 2007 2CryoLife Announces Record Preservation Services and Product Revenues for 2007 3CryoLife Announces Record Preservation Services and Product Revenues for 2007 4NIST develops test method for key micromechanical property 2Omeros Corporation Files Registration Statement for Proposed Initial Public Offering 2
(Date:11/25/2009)... Soil is the linchpin of the environment, where at... that, many students see soil as "just dirt" a pl... educators are challenged with the task of helping...portance of soil in the environment. , A collab...teachers at University of Nebraska-Lincoln, Oregon...
(Date:11/24/2009)...een prescribed by traditional healers in Brazil to...ach pain to fever and flu. , Now for the first ti...able to scientifically prove the pain relieving pr...razilian mint. , Testing this ancient South Ameri...ela Rocha was able to show that when prepared as a...
(Date:11/24/2009)...labby arteries from collapsing have been true life... longer needed -- once the arteries are strengthen...ad no choice but to leave them in place. , Prof....ent of Biomedical Engineering has developed a new ...here they,re needed, then dissolves. , "Our new ...
Breaking Biology News(10 mins):It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2Eliminate the Blues with Color Therapy 54599 1Eliminate the Blues with Color Therapy 54599 2Eliminate the Blues with Color Therapy 54599 3New nanolaser key to future optical computers and technologies 13581 1New nanolaser key to future optical computers and technologies 13581 2New nanolaser key to future optical computers and technologies 13581 3Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 1Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 2Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 3Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 54596 4
...Foundation, through its Autism Research Initiative...h the Rutgers University Cell and DNA Repository (...r autism studies. The samples will be collected fr...d. , The Simons Simplex Collection, as this proj...r a new and different line of research into the ge...
...September 04, 2007 - The term "biotechnology" elic...ar and hostility. Alan McHughen from the Universit... at large the current state public knowledge of bi...cy and the role of the media. How is coexistence d...agricultural biotech only big companies or also t...
...h showing that dog-walking in bushland significant...support to bans against the practice in sensitive ...uments and debate about the ecological impacts of ...d because experimental evidence has been lacking. ...e dogs as predators and avoid dog-walking areas is...
Other Biology News:Rutgers Genetics receives $7.8 million for autism research 2Rutgers Genetics receives $7.8 million for autism research 3How the public perceives biotech 2A dog in the hand scares birds in the bush 2
Sheep Anti-Human CATHEPSIN G Polyclonal Antibody, Unconjugated from AbD Serotec
Flammable Chemical Cabinets, Justrite Model 25042 from South Coast Enterprises
Mouse Anti-Bovine CD335 Monoclonal Antibody, ALEXA FLUOR 488 Conjugated, Clone AKS1 from AbD Serotec
Sheep Anti-Human Aminopeptidase P1 / XPNPEP1 Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: